Clinical Trials Directory

Trials / Completed

CompletedNCT01020422

Sexuality After Reduction Mammaplasty

Sexuality and Depression Predictors Among Breast Hypertrophy Women Undergoing Reduction Mammaplasty

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Daniela Francescato Veiga · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to determine the impact of reduction mammaplasty on sexuality and depression predictors in women with macromastia.

Detailed description

Breast hypertrophy is a common condition among women. Reduction mammaplasty is an effective and well established procedure performed for the relief discomfort associated with breast hypertrophy. Female breasts play an important role in sexuality, thus, the main purpose of this study is to determine whether reduction mammaplasty could influence sexual function and depression predictors on women with breast hypertrophy.

Conditions

Interventions

TypeNameDescription
PROCEDUREReduction mammaplastySexual function of patients undergoing reduction mammaplasty will be assessed by the Female Sexual Function Index (FSFI) preoperatively and 3 and 6 months postoperatively.

Timeline

Start date
2008-07-01
Primary completion
2009-11-01
Completion
2011-09-01
First posted
2009-11-25
Last updated
2019-09-06

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01020422. Inclusion in this directory is not an endorsement.